About Unidad de Atencion Medica e Investigacion en Salud
"Centro de atención médica, investigación en salud. Sitio de investigación en salud. Laboratorio clínico. Administración de medicamentos. Sala de infusión."
Clinical Trials at Unidad de Atencion Medica e Investigacion en Salud
During the past decade, Unidad de Atencion Medica e Investigacion en Salud conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on
average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Unidad de Atencion Medica e Investigacion en Salud" #1 sponsor was "Shire" with 5 trials, followed by "Pfizer" with 3 trials
sponsored, "Genentech, Inc." with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
Clinical Trials Conditions at Unidad de Atencion Medica e Investigacion en Salud
According to Clinical.Site data, the most researched conditions in "Unidad de Atencion Medica e Investigacion en Salud" are
"Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Atopic Dermatitis" (1 trials), "COVID-19" (1 trials) and "Chronic Low Back Pain With a Neuropathic Component" (1 trials). Many other conditions were trialed in "Unidad de Atencion Medica e Investigacion en Salud" in a lesser frequency.
Clinical Trials Intervention Types at Unidad de Atencion Medica e Investigacion en Salud
Most popular intervention types in "Unidad de Atencion Medica e Investigacion en Salud" are "Drug" (12 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Ontamalimab" (4 trials), "GDC-0853" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Unidad de Atencion Medica e Investigacion en Salud
The vast majority of trials in "Unidad de Atencion Medica e Investigacion en Salud" are
15 trials for "All" genders.
Clinical Trials Status at Unidad de Atencion Medica e Investigacion en Salud
Currently, there are NaN active trials in "Unidad de Atencion Medica e Investigacion en Salud".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Unidad de Atencion Medica e Investigacion en Salud,
1 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Unidad de Atencion Medica e Investigacion en Salud, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".